The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bunnage Mark E. since 2026.
This trader's CIK number is 2100735.
At the time of last reporting, Bunnage Mark E. was the EVP, Chief Scientific Officer of Vertex Pharmaceuticals Inc / Ma. (stock ticker symbol VRTX).
Also see all insider trading activities at Vertex Pharmaceuticals Inc / Ma.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | VRTX | 0 | $0 | 2,021 | $930,529 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-02-11 | VRTX | Sale | 2,021 | 460.43 | 930,529 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bunnage Mark E. (EVP, Chief Scientific Officer of Vertex Pharmaceuticals Inc / Ma at the time of this reporting) see the Securities and Exchange Commission (SEC) website.